Reflections from news and commentary of the day
Subscribe To
Posts
Comments
Tuesday, February 23, 2021
Monoclonal antibodies against MERS coronavirus show promise in Phase 1 NIH-sponsored trial | National Institutes of Health (NIH)
Monoclonal antibodies against MERS coronavirus show promise in Phase 1 NIH-sponsored trial | National Institutes of Health (NIH): Antibodies were well tolerated and generally safe when administered simultaneously to healthy adults.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment